Search

The business of audiology: unbundling

Many professions, such as law, accounting, engineering and some areas of healthcare charge hourly rates in a fee-for-service model. Administratively, this can be a challenge to track hours, bill clients/patients, and collect payment, but this does lend toward greater transparency...

Industry interaction with the ENT speciality

I was enormously grateful for the chance to articulate my personal thoughts on ‘the industry interaction with the ENT clinical community’. To set a context, the term ‘industry’ refers to medical technology manufacturers and suppliers, in addition to pharmaceutical companies....

Loss of smell after COVID-19: a view from the patient forums

Patient advocate, Chrissi Kelly, founder of AbScent, talks about how the pandemic has changed the way we think about smell loss. The high prevalence of chemosensory impairment as a result of the SARS-CoV-2 virus has shone a much-needed spotlight on...

The evolution in management of microtia and atresia

The management of microtia and atresia has evolved significantly. Ossama Abdelhamid and Amr Abdelhamid explain how a multidisciplinary approach has become standard, with the aim of delivering individualised assessment and intervention that should target functional, structural, cosmetic and psychological aspects...

Biologic therapies for chronic rhinosinusitis with nasal polyps: a new paradigm

Surgery for nasal polyposis has evolved significantly in the last 30 years, and now the medical management may be on the cusp of a revolution. Biologics using monoclonal antibodies to target specific immune pathways have introduced a paradigm shift in...

Audiology Papers of the Year 2015-16

In this short review we have asked Melanie, Carolina, Josephine and Cherilee to consider the best article they have read in the last 12 months and provide us with a short review. All contributors have managed to succinctly highlight the...

Unanswered questions in adult ototoxicity associated with platinum-based chemotherapy

Do the potential side-effects on hearing and tinnitus need to be a ‘necessary evil’ of platinum-based chemotherapy? How strong is our evidence base when offering advice to patients and fellow clinicians? David Baguley and his team from the University of...

Development and review of a blended service in response to COVID-19

The COVID-19 pandemic has required healthcare services globally to show both resilience and ingenuity in redesigning services to meet the ever-changing needs of our patients. We hear about the redevelopment of clinical pathways within an hearing implant service, and the...

Muscle tension dysphagia: an underdiagnosed problem

In this article, the authors introduce the description of swallowing problems which have been recently attributed to muscle tension dysphagia (MTDg). The authors are clear that this is a diagnosis of exclusion, and it is important to rule out other...

Developing medical devices for children: opportunities and challenges

The development of medical devices for infants and children lags significantly behind the development of devices for adults. While in the United States the Food and Drug Administration (FDA) has set up incentives for developing child age-specific pharmaceuticals, there is...

Recalcitrant chronic rhinosinusitis: What to do next?

Whilst the majority of patients with chronic rhinosinusitis (CRS) will significantly improve with treatment, we are sometimes left with a ‘hard-core’ of nasal cripples who fail to improve despite our best efforts. How can we deal with these patients? Valerie...